# Chapter 15: Brief Psychotic Disorder

## The Biological and Neurological Basis of Brief Psychotic Disorder

### Introduction

Brief Psychotic Disorder (BPD), as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), represents a unique and often dramatic clinical entity characterized by the sudden onset of psychotic symptoms that persist for at least one day but less than one month, followed by a complete return to the premorbid level of functioning (Unknown, 2017). The core symptoms include delusions, hallucinations, disorganized speech, or grossly disorganized or catatonic behavior, with at least one of these being delusions, hallucinations, or disorganized speech (Unknown, 2017). A similar, though broader, category is described in the International Classification of Diseases (ICD-10) as Acute and Transient Psychotic Disorders (ATPD), which also emphasizes a sudden or abrupt onset (within two weeks), the presence of polymorphic or schizophrenic-like syndromes, and a frequent association with acute stress (Garrabé & Cousin, 2012).

From a biological and neurological perspective, BPD presents a compelling puzzle. Unlike chronic psychotic disorders such as schizophrenia, which are often associated with a persistent and sometimes deteriorating course (Jablensky, 2012), BPD is, by definition, a transient disturbance with full recovery (Unknown, 2017). This defining feature—complete remission—suggests a fundamentally different underlying pathophysiology, or perhaps a more resilient and effective set of compensatory neurobiological mechanisms, compared to more enduring psychotic illnesses. The frequent association with severe psychosocial stressors (Garrabé & Cousin, 2012; Gupta & Mamidi, 2022; Ntchana, 2022) points toward a powerful interplay between environmental triggers and an underlying biological vulnerability, a concept supported by "multiple-hit" models of psychosis etiology (Dodd, 2007).

Despite its distinct clinical profile, the specific biological and neurological underpinnings of BPD remain largely uninvestigated. The available literature is sparse, necessitating a theoretical framework constructed by drawing parallels from more extensively studied psychiatric and neurological conditions that share overlapping symptomatology. This chapter aims to synthesize a comprehensive, evidence-based overview of the potential biological mechanisms of BPD, acknowledging the speculative nature of this endeavor. By examining research on schizophrenia, mood disorders, stress-related disorders, epilepsy, and delirium, we can formulate plausible hypotheses regarding the neurobiology of BPD. We will explore the roles of neurotransmitter systems, neural circuits, genetic predispositions, and neurodevelopmental factors that may contribute to the acute onset, brief duration, and ultimate resolution of this enigmatic disorder. This approach allows us to construct a model of BPD as a syndrome of acute brain dysfunction, a transient failure of homeostatic mechanisms in the face of overwhelming stress, rather than a fixed or progressive encephalopathy (Kapfhammer, 2018; Roberts & Yeager, 2009).

### Neurobiological Systems

The sudden emergence of profound psychotic symptoms such as delusions and hallucinations, coupled with disorganized thought and behavior, strongly implies a significant, albeit temporary, dysregulation of core neurobiological systems (Unknown, 2017). While direct evidence from BPD populations is limited, a wealth of knowledge from related disorders, particularly schizophrenia, provides a robust foundation for hypothesizing the systems involved. These include neurotransmitter pathways, neuroendocrine stress-response axes, and the complex interplay between them.

#### Neurotransmitter Systems and Neuropharmacology

The clinical presentation of BPD, dominated by positive psychotic symptoms, points directly to the involvement of the brain's dopamine system (Unknown, 2017). The "dopamine hypothesis" of psychosis, originally formulated for schizophrenia, posits that an excess of dopaminergic activity, particularly in mesolimbic pathways, is linked to the emergence of symptoms like delusions and hallucinations (Dodd, 2007). This hypothesis is strongly supported by two key lines of evidence relevant to BPD. First, dopamine-stimulating drugs such as amphetamine and cocaine can induce psychotic symptoms that are phenomenologically similar to those seen in acute psychosis (Dodd, 2007; Mauri, 2016; Meza-Ruiz & Zúñiga-Escobar, 2023). Second, the mainstay of treatment for BPD, as with other psychotic disorders, involves antipsychotic medications, which are primarily dopamine D2 receptor blockers (Dodd, 2007; Unknown, 2017). The therapeutic efficacy of these agents in resolving the acute symptoms of BPD strongly suggests that a transient hyperactivity of the dopamine system, especially at the D2 receptor, is a critical neurochemical event in the disorder's pathophysiology (Dodd, 2007; Mauri, 2016). This hyperactivity may be particularly concentrated in limbic areas such as the nucleus accumbens and amygdala, consistent with postmortem findings in schizophrenia (Dodd, 2007).

However, a simple model of dopamine excess is likely insufficient. Other neurotransmitter systems are deeply interconnected with dopamine pathways and are implicated in the broader symptom profile of BPD, which can include emotional lability, anxiety, and confusion (Ntchana, 2022; Garrabé & Cousin, 2012). Serotonin (5-HT) systems, for instance, are known to modulate dopamine release and are implicated in psychosis (Dodd, 2007). The efficacy of atypical antipsychotics, which have actions on both D2 and various serotonin receptors (e.g., 5-HT2A), suggests a role for serotonergic hyperactivity in the complex symptomatology of acute psychoses (Dodd, 2007; Willner, 1984). Furthermore, serotonin is critically involved in mood regulation, and its dysregulation could contribute to the affective turmoil and anxiety that often accompany BPD episodes (Fiar et al., 2012; Praško et al., 2009). Discontinuation of serotonergic antidepressants can itself produce psychological symptoms like anxiety, irritability, and sleep disturbances, highlighting the system's role in maintaining emotional homeostasis (Rosenbaum & Zajecka, 1997; Chouinard & Chouinard, 2015).

The excitatory neurotransmitter glutamate and the primary inhibitory neurotransmitter gamma-aminobutyric acid (GABA) are also central to maintaining cortical equilibrium, and their imbalance is increasingly implicated in psychosis (Willner, 1984; Batinić et al., 2017). A failure of GABAergic inhibition, for example, can lead to cortical hyperexcitability and disorganized neuronal firing, potentially contributing to disorganized speech and thought (Dodd, 2007; Schwartz, 1990). Some research in schizophrenia points to a loss of GABAergic interneurons in the hippocampus, which could disinhibit dopamine pathways and contribute to psychosis (Dodd, 2007). This mechanism is particularly intriguing for BPD, given the hippocampus's role in stress processing and memory, and could link the experience of a severe stressor to the downstream development of psychosis (Garrabé & Cousin, 2012). The rapid onset and resolution of BPD may reflect a transient, stress-induced breakdown in this inhibitory control, which is later restored through homeostatic mechanisms. This framework aligns with the observation that benzodiazepines, which enhance GABAergic transmission, can be beneficial in managing acute agitation associated with psychosis (Dodd, 2007; Yersin, 1999).

Finally, norepinephrine systems, heavily involved in arousal, stress responses, and vigilance, are likely contributors (Dodd, 2007; Batinić et al., 2017). The hyperarousal, anxiety, and sleep disturbances common in acute psychotic states and stress disorders are consistent with noradrenergic hyperactivity (Snaith, 1994; Roberts & Yeager, 2009; Kapfhammer, 2018). The close temporal link between BPD and acute stressors strongly suggests that a surge in central noradrenergic activity, as part of the "fight-or-flight" response, could be a key precipitating neurochemical event (Garrabé & Cousin, 2012; van Praag et al., 2004).

#### Neuroendocrine and Stress Response Systems

The defining role of acute stress as a precipitant for BPD and ATPD places the neuroendocrine stress response system, particularly the hypothalamic-pituitary-adrenal (HPA) axis, at the center of its pathophysiology (Garrabé & Cousin, 2012; Kapfhammer, 2018; Roberts & Yeager, 2009). Exposure to severe psychological or physical stressors triggers a cascade beginning with the release of corticotropin-releasing factor (CRF) from the hypothalamus, which stimulates the pituitary to release adrenocorticotropic hormone (ACTH), ultimately leading to the adrenal gland's secretion of cortisol (van Praag et al., 2004; Kapfhammer, 2018). While this is an adaptive acute response, prolonged or extreme activation of the HPA axis can have deleterious effects on the brain, particularly on structures rich in glucocorticoid receptors like the hippocampus, amygdala, and prefrontal cortex (Sandi, 2013; van Praag et al., 2004).

It is plausible that in vulnerable individuals, an overwhelming stressor leads to an extreme and dysregulated HPA axis response, resulting in supraphysiological levels of cortisol that disrupt neural function (Kapfhammer, 2018; Sandi, 2013). This model is supported by the phenomenon of "steroid psychosis," where administration of high-dose corticosteroids can induce psychotic symptoms, including mood changes, delusions, and hallucinations, that are often indistinguishable from a primary psychotic episode (Amorim et al., 2019; Baloch, 1974). This iatrogenic condition provides a compelling neuroendocrine model for how an endogenous surge in stress hormones could precipitate the clinical picture of BPD.

Furthermore, the HPA axis is intricately linked with the monoamine neurotransmitter systems discussed previously. Cortisol can modulate the synthesis, release, and reuptake of dopamine, norepinephrine, and serotonin, providing a direct mechanism through which a severe stress response could trigger the neurotransmitter imbalances thought to underlie psychotic symptoms (van Praag et al., 2004; Fiar et al., 2012). For example, chronic stress and elevated cortisol can lead to structural and functional changes in the hippocampus and prefrontal cortex, areas crucial for cognitive control and emotional regulation (Sandi, 2013). A sudden, massive stress-induced disruption of these circuits could plausibly lead to the transient cognitive disorganization and emotional lability seen in BPD (Garrabé & Cousin, 2012; Kapfhammer, 2018). The full remission characteristic of BPD (Unknown, 2017) may reflect the eventual restoration of HPA axis homeostasis and the resilience of these neural circuits once the acute stressor has passed and cortisol levels normalize.

### Genetic and Molecular Basis

While environmental stressors are clearly implicated in triggering Brief Psychotic Disorder (Garrabé & Cousin, 2012; Ntchana, 2022), the observation that not all individuals exposed to severe trauma develop psychosis suggests the presence of an underlying genetic vulnerability (Kapfhammer, 2018). The biology of BPD is likely governed by a gene-environment interaction, consistent with the "two-hit" or "multiple-hit" model proposed for schizophrenia, where a pre-existing genetic predisposition requires an environmental insult to manifest clinically (Dodd, 2007).

#### Heritability and Shared Genetic Vulnerability

Direct genetic studies of BPD are scarce. However, its phenomenological overlap with other psychotic and affective disorders, such as schizophrenia and bipolar disorder, suggests the possibility of a shared genetic diathesis (Dodd, 2007; Buckley & Foster, 2014). Schizophrenia, for example, has a strong genetic component; twin studies show a concordance rate of nearly 50% for monozygotic twins compared to 17% for dizygotic twins (Dodd, 2007). Siblings of individuals with schizophrenia have a 10% risk of developing the disorder themselves, far greater than the 1% lifetime prevalence in the general population (Dodd, 2007; Buckley & Foster, 2014). While BPD is nosologically distinct due to its duration and outcome, it is plausible that it lies on a spectrum of psychotic vulnerability, sharing some of the same risk alleles as schizophrenia or schizoaffective disorder (Tso et al., 2010; Hong, 2013).

A family history of mood disorders may also be a relevant predisposing factor (Dodd, 2007; Tso et al., 2010). The polymorphic and often affect-laden presentation of ATPD (Garrabé & Cousin, 2012), with features of mania or depression, suggests a potential genetic link to bipolar disorder, which also has a strong heritable component (Padmos, 2009; Tiller & Schweitzer, 2010). It is conceivable that individuals who develop BPD possess a genetic loading for psychosis or mood instability, but also possess other genetic or epigenetic resilience factors that promote rapid recovery and prevent the development of a chronic illness (Jablensky, 2012). Therefore, BPD might represent a specific manifestation of this vulnerability, unmasked by an acute, overwhelming stressor (Garrabé & Cousin, 2012; Kapfhammer, 2018).

#### Candidate Genes and Molecular Mechanisms

Given the lack of specific molecular research in BPD, we must again extrapolate from schizophrenia genetics to identify potential candidate pathways. Research in schizophrenia has implicated multiple chromosomal linkages, including regions on chromosomes 5q, 6p, 8p, 13q, and 22q, among others (Dodd, 2007). Genes located in these regions are involved in a wide array of neurodevelopmental and neurophysiological processes, such as neuronal migration, synaptic pruning, and neurotransmitter regulation, particularly involving the dopamine and glutamate systems (Dodd, 2007; Stringer et al., 2015).

Genes regulating the dopamine system are of particular interest. For example, variations in genes for dopamine receptors (e.g., DRD2, DRD3), dopamine transporters, or enzymes that metabolize dopamine could influence an individual's sensitivity to stress-induced dopamine release, potentially predisposing them to psychosis under conditions of extreme duress (Dodd, 2007; Fiar et al., 2012). Similarly, genes involved in the glutamate system, such as those coding for NMDA receptor subunits, are critical candidates, as NMDA receptor antagonism can produce schizophrenia-like psychosis (Willner, 1984; Pontius, 1993).

Another intriguing molecular mechanism that could be relevant to BPD is "kindling," a process of neuronal sensitization. It has been proposed that repeated, sub-threshold stressful experiences could "kindle" limbic circuits, lowering the threshold for a seizure-like, disorganized discharge in response to a subsequent major stressor (Pontius, 1993; Pontius, 2001). This "limbic psychotic trigger reaction" model suggests that a specific, individualized stimulus triggers a memory revival of past hurts, leading to a brief, transient psychosis with autonomic hyperactivation and full recall, a description bearing a striking resemblance to some presentations of BPD (Pontius, 1993; Pontius, 2001; Hollender & HIRSCH, 1964). This process implicates molecular changes in synaptic plasticity and long-term potentiation within limbic structures, making genes related to these functions potential candidates for BPD vulnerability. The abrupt onset and transient nature of BPD align well with such a paroxysmal, seizure-like model of brain dysfunction (Garrabé & Cousin, 2012; Pontius, 1993).

### Brain Structure and Function

The acute and profound disturbances in perception, thought, emotion, and behavior that define Brief Psychotic Disorder strongly suggest a transient but significant disruption of brain function (Unknown, 2017). Although dedicated neuroimaging studies of BPD are virtually nonexistent in the provided literature, findings from schizophrenia, mood disorders, and related neurological conditions can be used to construct a hypothetical model of the neural circuits and structural factors that may be involved.

#### Neuroimaging Findings: Clues from Related Disorders

Structural neuroimaging studies in schizophrenia have consistently identified several abnormalities, the most robust being ventricular enlargement, particularly of the third and lateral ventricles (Dodd, 2007). Other common findings include a selective reduction in the volume of medial temporal lobe structures (such as the hippocampus and amygdala), the thalamus, and the frontal and temporal lobes, along with sulcal widening (Dodd, 2007). These findings are generally interpreted as evidence of a neurodevelopmental abnormality and are associated with a poorer prognosis (Dodd, 2007). It is an open question whether individuals who experience BPD exhibit subtle, pre-existing structural variations in these same regions that might confer vulnerability. However, the complete functional recovery seen in BPD makes it unlikely that patients have the same degree of gross structural pathology as is often found in chronic schizophrenia (Unknown, 2017; Jablensky, 2012). Any predisposing structural markers in BPD would likely be far more subtle.

Functional neuroimaging in schizophrenia, particularly using positron emission tomography (PET), has famously revealed a pattern of "hypofrontality," or reduced metabolic activity and blood flow in the frontal and prefrontal cortex, especially during tasks that require executive function (Dodd, 2007). This frontal lobe dysfunction is thought to be closely linked to the negative symptoms and neurocognitive deficits of schizophrenia (Dodd, 2007; Buckley & Foster, 2014). While BPD is not defined by negative symptoms, the presence of disorganized speech and behavior strongly implicates a transient failure of frontal executive control (Unknown, 2017; Dodd, 2007). It is plausible that during an episode of BPD, individuals experience a temporary, stress-induced state of hypofrontality, leading to a breakdown in the ability to organize thought and behavior (Kapfhammer, 2018; Sandi, 2013).

Functional imaging has also implicated a network of regions in the generation of positive symptoms. For instance, PET studies suggest that the inferotemporal cortex, basal ganglia, and thalamus are involved in the generation of visual hallucinations (Dodd, 2007). This circuit, which is involved in visual processing, may become pathologically active due to increased dopaminergic activity in the basal ganglia, leading to altered visual perception (Dodd, 2007). Similarly, auditory hallucinations have been linked to hyperactivity in auditory processing areas of the temporal lobe (Dodd, 2007; Buckley & Foster, 2014). The transient hallucinations in BPD likely arise from a similar, temporary dysregulation within these specific sensory-processing circuits (Unknown, 2017; Pontius, 1993).

#### Neural Circuits and Functional Connectivity

Based on the symptomatology of BPD and knowledge from related disorders, a model of transient cortico-limbic circuit dysregulation appears most compelling. This model posits that BPD arises from a temporary breakdown in the balance between "bottom-up" limbic drives and "top-down" cortical control (van Praag et al., 2004; Sandi, 2013).

The limbic system, including the amygdala and hippocampus, is central to processing emotion, threat, and stress (Dodd, 2007; Pontius, 1993). Given that BPD is often precipitated by a severe stressor (Garrabé & Cousin, 2012), it is hypothesized that this system becomes hyperactive. This limbic hyperactivity, fueled by a surge in stress hormones and monoamines, could generate the intense anxiety, emotional lability, and perceptual disturbances (e.g., hallucinations) that characterize the acute phase (Kapfhammer, 2018; Pontius, 2001). Some have even proposed that the acute episode represents a "limbic psychotic trigger reaction," akin to a non-convulsive limbic seizure, reflecting extreme neuronal hyperexcitability in these structures (Pontius, 1993; Pontius, 2001). This is consistent with the observation that complex partial seizures originating in the temporal lobe can present with psychiatric symptoms like psychosis, fear, and affective changes (Kruse, 1990; Stern & Murray, 1984; Nadkarni et al., 2007).

Simultaneously, the prefrontal cortex (PFC), which is responsible for executive functions like planning, impulse control, and reality testing, appears to temporarily lose its ability to modulate these limbic outputs (Dodd, 2007). This failure of top-down control could result in the disorganized speech, bizarre behavior, and poor judgment seen in BPD (Unknown, 2017; Dodd, 2007). The state of hypofrontality observed in schizophrenia may therefore be a transient, functional state in BPD, rather than a fixed structural or metabolic deficit (Dodd, 2007).

Key subcortical structures, such as the thalamus and basal ganglia, act as critical relay stations within these circuits (Dodd, 2007). The thalamus filters sensory information before it reaches the cortex, and dysfunction here could contribute to perceptual distortions and hallucinations (Dodd, 2007). The basal ganglia, heavily modulated by dopamine, are involved in integrating motor, cognitive, and emotional information (Dodd, 2007; Macpherson & Hikida, 2018). A transient dopamine surge in the basal ganglia could disrupt these integrative functions, contributing to both motor abnormalities (catatonia, disorganized behavior) and psychotic symptoms (Dodd, 2007; Pontius, 1993). The complete and rapid recovery seen in BPD implies that the underlying functional connectivity of these cortico-limbic circuits is fundamentally intact, but temporarily overwhelmed by an acute neurochemical and neuroendocrine storm (Unknown, 2017; Kapfhammer, 2018).

### Developmental Neurobiology

The onset of Brief Psychotic Disorder, like many primary psychotic disorders, typically occurs in late adolescence or early adulthood, a critical period of brain development and maturation (Unknown, 2017; Buckley & Foster, 2014; Marcello & Silverstein, 2010). This temporal clustering suggests that the neurobiological vulnerability to BPD may be rooted in developmental processes that render the brain particularly susceptible to stressors during this life stage. The neurodevelopmental model of schizophrenia provides a useful framework for conceptualizing this vulnerability, positing that a combination of genetic and early environmental factors (the "first hit") leads to subtle brain abnormalities that remain clinically silent until a later maturational stage or environmental challenge (the "second hit") triggers the onset of psychosis (Dodd, 2007; Jablensky, 2012).

#### Neurodevelopmental Vulnerability and Critical Periods

In the context of BPD, the "first hit" may involve a less severe or different pattern of neurodevelopmental disruption than that seen in schizophrenia. While schizophrenia is associated with premorbid developmental delays, cognitive deficits, and social withdrawal that can be traced back to childhood (Dodd, 2007; Jablensky, 2012; Alderton, 1966), the diagnosis of BPD requires a return to the *premorbid* level of functioning, which is often, though not always, normal (Unknown, 2017). This suggests that any underlying vulnerability may be more subtle, perhaps consisting of a latent hypersensitivity of the HPA axis or a lower threshold for stress-induced dopamine dysregulation rather than gross structural or functional deficits (van Praag et al., 2004; Kapfhammer, 2018).

Adolescence is a period of significant synaptic pruning, myelination, and refinement of cortico-limbic circuits, particularly in the prefrontal cortex (PFC) (Sommer & Arango, 2017). This ongoing maturation is crucial for the development of adult executive functions and emotional regulation (Dodd, 2007). It is also a period of heightened sensitivity to psychosocial stressors (Zauner, 1978). It is plausible that in individuals vulnerable to BPD, these late neurodevelopmental processes create a temporary window of instability. A severe stressor (the "second hit") encountered during this period could disrupt the still-maturing PFC's ability to regulate stress-induced hyperactivity in limbic regions, leading to a transient psychotic break (Garrabé & Cousin, 2012; Kapfhammer, 2018). The capacity for full recovery in BPD would then reflect the fundamental integrity of the underlying neural architecture, which is able to re-establish homeostatic control once the acute perturbation subsides (Unknown, 2017).

This contrasts with schizophrenia, where the neurodevelopmental insult is thought to be more profound, resulting in a more compromised neural substrate that is less capable of recovery and more prone to a chronic course (Jablensky, 2012; Arnold, 1999). Therefore, BPD could be conceptualized as a disorder of *functional decompensation* in a vulnerable but largely intact developing brain, whereas schizophrenia may represent a disorder of *structural and functional maldevelopment* (Dodd, 2007; Jablensky, 2012).

#### The Role of Early Life Stress and Trauma

Early life adversity, such as childhood trauma or abuse, is a significant risk factor for a wide range of adult psychiatric disorders, including psychosis (Kapfhammer, 2018; Hosseinbor & Bakhshani, 2014). Such experiences can have lasting effects on neurodevelopment, particularly on the calibration of the HPA axis and the development of limbic-prefrontal circuits involved in emotion regulation and stress resilience (van Praag et al., 2004; Sandi, 2013). A history of early trauma may serve as a potent "first hit," sensitizing these systems and lowering the threshold for psychosis in response to later stressors (Kapfhammer, 2018). This sensitization may occur via epigenetic mechanisms that alter the expression of genes involved in the stress response, leading to a state of heightened biological vulnerability (van Praag et al., 2004).

The clinical presentation of BPD often includes dissociative symptoms, emotional lability, and a clear temporal link to a precipitating event, features that overlap significantly with acute stress disorder and posttraumatic stress disorder (PTSD) (Garrabé & Cousin, 2012; Kapfhammer, 2018; Miller et al., 2010). This overlap suggests a shared neurobiological substrate related to trauma processing. It is possible that BPD represents one end of a spectrum of trauma-related disorders, where the response to an acute stressor manifests primarily as psychosis rather than the classic re-experiencing and avoidance symptoms of PTSD (Miller et al., 2010). The neurodevelopmental history of the individual, shaped by both genetic and early environmental factors, may determine whether a severe stressor in early adulthood results in BPD, PTSD, a major depressive episode, or an adaptive stress response (Kapfhammer, 2018; van Praag et al., 2004).

### Treatment Mechanisms

The management of Brief Psychotic Disorder primarily focuses on ensuring patient safety, alleviating acute symptoms, and facilitating a return to normal functioning (Unknown, 2017). The biological basis of effective treatments, particularly pharmacotherapy, provides further insight into the underlying neurochemistry of the disorder. Furthermore, the hallmark of BPD—full recovery—points towards powerful endogenous mechanisms of neuroplasticity and compensation that distinguish it from chronic psychotic illnesses.

#### Pharmacological Interventions and Their Neurobiological Targets

The mainstay of pharmacological treatment for the acute symptoms of BPD is antipsychotic medication (Unknown, 2017). These medications, originally developed for schizophrenia, are highly effective in reducing positive symptoms such as hallucinations and delusions (Dodd, 2007; Mauri, 2016). The primary mechanism of action for both first-generation ("typical") and second-generation ("atypical") antipsychotics is the blockade of dopamine D2 receptors, particularly in the mesolimbic pathway (Dodd, 2007). The rapid efficacy of these agents in mitigating the florid psychosis of BPD provides strong corroborating evidence for the dopamine hyperactivity hypothesis as a core component of the acute episode (Dodd, 2007; Mauri, 2016). By blocking postsynaptic D2 receptors, these drugs are thought to dampen the excessive dopaminergic signaling that drives aberrant salience and the formation of psychotic experiences (Dodd, 2007; Thomas & Pantelis, 2015).

Atypical antipsychotics, such as risperidone, olanzapine, and quetiapine, have a broader receptor binding profile, notably including potent antagonism at serotonin 5-HT2A receptors in addition to D2 blockade (Dodd, 2007; Montes & Rey, 2009). This dual action is hypothesized to contribute to their efficacy and potentially a more favorable side-effect profile regarding extrapyramidal symptoms (Dodd, 2007). The effectiveness of these agents in BPD suggests that serotonin dysregulation may also play a significant role, perhaps contributing to the mood lability and anxiety often seen alongside the core psychotic symptoms (Tso et al., 2010; Garrabé & Cousin, 2012).

In cases of severe agitation or catatonic features, which can occur in BPD, benzodiazepines like lorazepam may be used as an adjunctive treatment (Dodd, 2007; Unknown, 2017). Benzodiazepines are positive allosteric modulators of the GABAA receptor, enhancing the effect of the brain's primary inhibitory neurotransmitter, GABA (Pétursson, 1994). Their utility in calming agitation and resolving some catatonic signs suggests that a state of cortical hyperexcitability, potentially due to a transient failure of GABAergic inhibition, may be part of the acute pathophysiology of BPD (Dodd, 2007; Francis, 2006).

Unlike in chronic schizophrenia, where long-term maintenance therapy is the standard of care to prevent relapse (Dodd, 2007; Jablensky, 2012), medication for BPD is typically short-term. Treatment is often continued for 1 to 3 months after symptom remission and then gradually tapered (Dodd, 2007). The ability to successfully discontinue medication without relapse is a key clinical feature that reflects the transient nature of the underlying neurobiological disturbance.

#### Neuroplasticity, Compensatory Mechanisms, and Recovery

The most defining biological characteristic of BPD is its resolution. The complete return to premorbid functioning within one month implies the existence of robust homeostatic and neuroplastic mechanisms that are capable of fully restoring normal brain function (Unknown, 2017). This stands in stark contrast to the course of schizophrenia, where recovery is often incomplete, and persistent negative and cognitive symptoms suggest a more enduring, possibly structural, brain deficit (Jablensky, 2012; Arnold, 1999; Harvey, 2010).

The recovery from BPD can be conceptualized as a process of neurobiological resilience. Following the acute, stress-induced cascade of neurochemical and neuroendocrine dysregulation (e.g., dopamine/serotonin hyperactivity, HPA axis overdrive), the brain's homeostatic systems appear to successfully re-engage (Kapfhammer, 2018; van Praag et al., 2004). This likely involves multiple processes: downregulation of over-sensitized dopamine receptors, normalization of HPA axis feedback loops, restoration of GABAergic inhibitory tone, and re-establishment of stable functional connectivity within cortico-limbic circuits (Dodd, 2007; van Praag et al., 2004).

This capacity for full recovery suggests that the underlying neural architecture in individuals who experience BPD is fundamentally sound, unlike the compromised architecture hypothesized in schizophrenia (Jablensky, 2012). The psychotic episode may represent a "system overload"—a transient state where the brain's capacity to process an extreme stressor is temporarily exceeded, leading to a brief period of functional disorganization (Kapfhammer, 2018; Roberts & Yeager, 2009). Once the stressor is removed or attenuated, and with the help of acute pharmacological intervention to stabilize the system, these resilient brains can recalibrate and return to their baseline state. Understanding the molecular and cellular mechanisms that underpin this remarkable neuroplasticity—what allows the brain to "re-set" after a psychotic episode—is a critical area for future research and may hold the key to developing interventions that promote recovery across the entire psychosis spectrum.

### Future Directions

The biological understanding of Brief Psychotic Disorder is in its infancy, largely constructed from inference and analogy rather than direct investigation. The current literature, drawn from studies of related but distinct disorders, provides a foundational but speculative framework. The path forward requires a dedicated research focus on BPD itself, leveraging modern neuroscience tools to move from hypothesis to direct evidence.

A primary imperative is the initiation of prospective, longitudinal neuroimaging studies of individuals presenting with a first episode of brief psychosis. Utilizing structural and functional magnetic resonance imaging (MRI and fMRI) and positron emission tomography (PET) from the acute phase through to remission would be invaluable (Dodd, 2007). Such studies could determine whether individuals with BPD have subtle, pre-existing structural vulnerabilities (e.g., in hippocampal or prefrontal volume) or trait-like patterns of functional connectivity that predispose them to psychosis under stress. Critically, longitudinal imaging could capture the transient functional changes during the psychotic state—such as potential hypofrontality or limbic hyperactivity—and track their normalization during recovery, providing a direct window into the neuroplastic mechanisms of remission (Dodd, 2007; Seitz, 2005).

Genetic research must also move beyond assuming a shared etiology with schizophrenia. While genome-wide association studies (GWAS) of schizophrenia provide a list of candidate genes (Stringer et al., 2015), future studies should specifically recruit and analyze cohorts of BPD patients. This could identify unique genetic risk factors for BPD or, perhaps more importantly, identify "resilience genes" that are enriched in BPD patients compared to those with schizophrenia. These resilience factors might be involved in more robust stress-response regulation, enhanced synaptic plasticity, or more effective neuroprotective mechanisms, explaining the favorable, self-limiting course of the illness (Jablensky, 2012).

Investigating the neurobiology of the stress response in BPD is another crucial avenue. Detailed examination of the HPA axis and sympathetic nervous system function in patients during and after an episode could clarify whether BPD is characterized by a uniquely exaggerated, but ultimately reversible, physiological response to stress (Kapfhammer, 2018). This could involve measuring cortisol, ACTH, and catecholamine levels in response to standardized psychosocial stress tests in remitted BPD patients and comparing them to healthy controls and individuals with schizophrenia or PTSD (van Praag et al., 2004). Such research could identify biomarkers of vulnerability and illuminate the link between psychological trauma and biological decompensation.

Furthermore, the potential role of neuroinflammation and immune dysregulation, increasingly recognized in both psychosis and stress, warrants investigation in BPD (Padmos, 2009; Ferguson & Cassaday, 2001). Acute stressors can trigger a powerful inflammatory response, and it is plausible that in some individuals, this contributes to the transient neuronal dysfunction underlying psychosis (Kapfhammer, 2018). Measuring inflammatory markers (e.g., cytokines) in the blood and cerebrospinal fluid of acute BPD patients could reveal a treatable biological substrate.

Finally, exploring the boundary between BPD and neurological conditions is essential. The clinical overlap with non-convulsive status epilepticus, particularly of temporal or frontal origin, suggests that some cases of BPD may represent an ictal or post-ictal phenomenon (Kruse, 1990; Krumholz et al., 1995; Walker et al., 1996). Systematic and prolonged electroencephalogram (EEG) monitoring in patients with acute, brief psychosis is needed to clarify the prevalence of underlying epileptiform activity (Mani, 2022). This could lead to a reclassification of a subset of BPD cases and guide more targeted treatment with anticonvulsants rather than antipsychotics (Thomas, 2003).

### Conclusion

Brief Psychotic Disorder stands as a distinct clinical syndrome at the intersection of stress, vulnerability, and resilience. While the precise biological and neurological mechanisms remain to be fully elucidated, this chapter has synthesized a plausible, albeit hypothetical, model based on the available literature concerning related neuropsychiatric disorders. The emerging picture is that of a condition rooted in a transient, profound dysregulation of key neural systems, rather than a permanent structural deficit.

The core of this model involves a vulnerable brain, likely predisposed by genetic factors that may overlap with those for schizophrenia and mood disorders (Dodd, 2007). This vulnerability is unmasked by an acute, overwhelming psychosocial stressor, which triggers a neurobiological cascade (Garrabé & Cousin, 2012; Kapfhammer, 2018). This cascade is characterized by hyperactivity of the HPA axis and a consequent storm of neurotransmitter release, most notably a surge in mesolimbic dopamine, but also involving serotonin, norepinephrine, and glutamate systems (Dodd, 2007; van Praag et al., 2004). This neurochemical imbalance leads to a temporary failure of functional connectivity, particularly a breakdown in the top-down control exerted by the prefrontal cortex over hyperactive limbic structures (Dodd, 2007; Pontius, 1993). The clinical result is the florid presentation of psychosis: a temporary disruption of perception, thought, and behavior (Unknown, 2017).

However, the defining feature of BPD is not its onset but its offset. The complete and rapid return to premorbid functioning underscores the most critical aspect of its underlying biology: resilience (Unknown, 2017). Unlike in schizophrenia, where the neurodevelopmental foundation may be fundamentally compromised (Jablensky, 2012), the brain in BPD appears to possess robust homeostatic and neuroplastic mechanisms. These systems are capable of weathering the acute storm, re-establishing equilibrium, and restoring normal function. This capacity for full recovery suggests that the study of BPD offers a unique natural experiment in neurobiological resilience. Unraveling the mechanisms that allow for this complete remission may not only illuminate the specific pathophysiology of BPD but could also provide crucial insights into promoting recovery and preventing chronicity across the entire spectrum of psychotic disorders.

## References

1. Abdelsayed, S., Acevedo, R., & Clemow, L. (2017). Is sleep deprivation associated with behavioral changes in children and adolescents?. Evidence-Based Practice. https://doi.org/10.1097/01.ebp.0000541629.93211.cb
2. Adam, B. W., Lunow, M., & Seidel, G. (2010). Pseudo-Conn-Syndrom mit hypokaliämischer Lähmung bei Lakritzabusus und Diuretikatherapie. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0029-1245912
3. Ademi, L. A., & Ademi, B. (2017). EVALUATION AND MANAGEMENT OF A CHILD WITH FEBRILE SEIZURE.
4. Ahemad, M., Ahmad, P. M. F., & Shafaat, M. (2018). Effect of Dalak (Massage) in the Management of Sahar (Insomnia). https://doi.org/10.37591/rrjoush.v5i2.130
5. Al-Balawi, T., Al-Greeshah, F., & Khan, S. (2003). Management of status epilepticus.. PubMed.
6. Alderton, H. R. (1966). A Review of Schizophrenia in Childhood. Canadian Psychiatric Association Journal. https://doi.org/10.1177/070674376601100403
7. Alexandre, S., Misery, L., Dutray, S., Chastaing, M., Consoli, S.-M., Audra, H., Bauer, D., Bertolus, S., Callot, V., Cardinaud, F., Corrin, E., Féton-Danou, N., Malet, R., Touboul, S., & Consoli, S. (2007). Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-0266
8. Ali, M., Malathesh, B. C., Chatterjee, S. S., Das, S., & Prasad, S. (2022). Mania/Hypomania induced by quetiapine: A case report and review of literature. Psychiatry Research Case Reports. https://doi.org/10.1016/j.psycr.2022.100093
9. Allen, P., Setya, A., & Lawrence, V. N. (2019). Pediatric Functional Constipation.
10. Alvarado, R., Shilling, S., & Jorquera, M. J. (2015). Uso de la Intervención Critical Time Intervention en personas con primer episodio de psicosis. Revista de la Facultad de Ciencias Médicas de Córdoba. https://doi.org/10.31053/1853.0605.v72.n4.13845
11. Alvarez, M. R., García, R. G., & Silva, F. A. (2010). Cefalea por uso excesivo de medicamentos: implicaciones clínicas y terapéuticas. Acta neurológica colombiana.
12. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
13. Ananto, A. S., & Suryati, E. (2019). Ensefalopati Hipertensi pada Anak dengan Glomerulonefritis Akut Pasca Streptokokal.
14. Anderson, M. (2010). Benzodiazepines for prolonged seizures. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/adc.2009.176321
15. Andresen, M., & Andresen-Vasquez, M. (2016). A new instrument for assessing the experience of dying and death in the intensive care units from the perspective of relatives. Journal of Thoracic Disease. https://doi.org/10.21037/jtd.2016.06.07
16. Antoniuk, S. A. (2013). [Non-epileptic disorders in infancy and adolescence].. PubMed.
17. Arenson, C., Busby‐Whitehead, J., Brummel‐Smith, K., O’Brien, J. G., Palmer, M. H., & Reichel, W. (2010). Evaluation and Management of Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575952.017
18. Arnold, S. E. (1999). Schizophrenia. Humana Press eBooks. https://doi.org/10.1007/978-1-4612-1602-5_27
19. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2013). Nonconvulsive status epilepticus and psychotic symptoms: case report.. PubMed. https://doi.org/10.1708/1292.14295
20. Ashraf, M., Sheikher, C., Farooq, A., & Ahmed, J. (2012). Shuddering attacks: Should an EEG be ordered. Biomedical Reports.
21. Ayala, L., Gómez‐Revuelta, M., Requena, C. M., Acilu, E. S. D. A. G. D., Olivares, O. P., Ruíz, M. J., Morales, N. N., Martin, M., Zufiaurre, M. L., Hernández, B., Itoiz, A. A., Peña, M., & González‐Pinto, A. (2017). Clozapine: Since the very beginning?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.1402
22. Baloch, N. S. (1974). ‘Steroid Psychosis’: A Case Report. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.124.6.545
23. Ban, N., Saiki, T., Ko, G., & Kuwahata, A. (2007). [Clinical features of chronic fatigue syndrome--symptoms].. PubMed.
24. Bano, S., Das, S., Mazumder, A., Das, S., & Aman, S. (2015). The Landau Kleffner Syndrome.
25. Barbosa, M. O. S., Silva, F. L. C., Castro, J. D. O., Marino, L. D. B., Silva, V. D. S., Pinho, R. C., & Bonfim, Y. C. (2018). PROCESSO DE ENFERMAGEM EM PACIENTE COM ESQUIZOFRENIA HEBEFRÊNICA: UM RELATO DE CASO. 13º Congresso Internacional Rede Unida.
26. Barnhill, J. W., Hilty, D. M., Gitlin, M., Oquendo, M. A., Cosgrove, V. E., Suppes, T., Findling, R. L., Ferrando, S. J., Daniels, J., Jones, M., & Swartz, H. A. (2023). Bipolar and Related Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615375295.jb03
27. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
28. Bd, S. (1990). Early information processing in schizophrenia.. Psychiatric medicine.
29. Becker, M. A., Weinberger, T. E., & Ocker, L. J. (2022). Mood Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003099062-21
30. Belagaje, S., & Bonomo, J. (2012). A Person with Factitious Disorder Presenting with Acute Stroke-Like Symptoms and Receiving Thrombolytic Therapy Twice. Journal of Clinical Case Reports. https://doi.org/10.4172/2165-7920.1000138
31. Bentes, C., & Pimentel, J. G. (2012). Estado de mal convulsivo. Aspectos fisiopatológicos e clínicos.. Acta Médica Portuguesa. https://doi.org/10.20344/amp.1154
32. Bereda, G. (2022). Stage and symptoms of bipolar disorders. Insights on the Depression and Anxiety. https://doi.org/10.29328/journal.ida.1001030
33. Bertodo, T. D. S., Gross, M. S., & Maldaner, E. B. (2018). TRANSTORNOS BIPOLAR E DEPRESSIVO: UMA REVISÃO DOS ASPECTOS CONCEITUAIS.
34. Besag, F., Gobbi, G., Aldenkamp, A. P., Caplan, R., Dunn, D. W., & Sillanpää, M. (2016). Psychiatric and Behavioural Disorders in Children with Epilepsy (ILAE Task Force Report): Subtle behavioural and cognitive manifestations of epilepsy. Epileptic Disorders. https://doi.org/10.1684/epd.2016.0816
35. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
36. Blackburn, L. B., Zelko, F., & Shurtleff, H. A. (2001). Seizure disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545894.008
37. Bobylova, M. Y. (2022). Therapy with Cogitum in children with speech disorders. Russian Journal of Child Neurology. https://doi.org/10.17650/2073-8803-2022-17-2-30-36
38. Bonnet, M. H., & Arand, D. L. (2013). Insomnia. https://doi.org/10.3920/9789086867639_003
39. Borchert, A., Möddel, G., & Schilling, M. (2009). Teaching Video Neuro <i>Images</i> : Paroxysmal kinesigenic dyskinesia. Neurology. https://doi.org/10.1212/wnl.0b013e3181a92b66
40. Bosanac, B., Dominik, P., Gabrić, P., Hrstić, A., Ključarić, D. K., Kužina, I., Sović, M. S., & Vandek, M. (2017). Lexical-semantic categorisation in patients of schizophrenia. https://doi.org/10.5281/zenodo.4681378
41. Bouchard, S., Robillard, G., Larouche, S., & Loranger, C. (2012). Description of a Treatment Manual for in virtuo Exposure with Specific Phobia. InTech eBooks. https://doi.org/10.5772/46417
42. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
43. Bueno, B. B., Soares, V. S., & Oliveira, C. F. D. (2014). Patologias associadas à deficiências na síntese do grupo heme. Revista Científica da FHO|Uniararas. https://doi.org/10.55660/revfho.v2i2.101
44. Bulcke, L. V. D., & Bossche, M. V. D. (2022). 0855 A challenging case of nocturnal visual hallucinations in an elderly woman. SLEEP. https://doi.org/10.1093/sleep/zsac079.849
45. Burkart, J., Jong, M. C., Ilenkyo, L., Verwer, C., Weber, S., Keller, T., & Klement, P. (2017). P172 Results of a randomised controlled trial with a homeopathic complex medicinal product in children with sleep disorders and restlessness. https://doi.org/10.1136/archdischild-2017-313273.260
46. Burke, A., Yaari, R., Tariot, P. N., Dougherty, J., Fleisher, A., & Brand, H. (2012). The Shadow People. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12alz01398
47. Burnett, M. S. (2015). Hyperkinetic Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244927.003.0027
48. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Le retard mental. Le point sur... Psychologie.
49. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Les troubles de l'humeur. Le point sur... Psychologie.
50. Carota, A., Diéguez, S., & Bogousslavsky, J. (2005). Psychopathology of stroke. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
51. Carrión, A., & Eduardo, C. (2015). Dispepsia: ¿Cómo actuar basado en evidencias?, ¿Orgánica o Funcional? ¿Cómo estudiarla y tratarla con fundamento científico?.
52. Chandra, D., Raj, K. S., & Prema (2018). Obstructive Sleep Apnea and Its Prosthodontic Management- An Overview. International Journal of Health Sciences and Research.
53. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
54. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
55. Charlesworth, J., Ghosn, O., Hussain, N., Mahmoud, R., Goncalves, V., & Godbole, M. (2023). A case report of an unusual presentation of a patient with recurrent idiopathic catatonia. Psychiatry Research Case Reports. https://doi.org/10.1016/j.psycr.2023.100111
56. Chaudhry, H., Arshad, N., Niaz, S., Cheema, F., Iqbal, M., & Mufti, K. (2005). Fifteen-year follow-up of conversion disorder. International Psychiatry. https://doi.org/10.1192/s1749367600007517
57. Chavan, R., Gosavi, M., Baviskar, M., & Goyal, N. P. (2023). Depression Detection using AI, ML and NLP. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-8886
58. Chiu, Y. C. (2015). Behavioral-Variant Frontotemporal Neurocognitive Disorder Presenting as Insomnia. Journal of Psychiatry. https://doi.org/10.4172/2378-5756.1000298
59. Choi, W., & Young, M. J. (2023). Disambiguating Consciousness in Clinical Settings. Neurology. https://doi.org/10.1212/wnl.0000000000207765
60. Chouinard, G., & Chouinard, V. (2015). New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000371865
61. Chouliaras, L., Topiwala, A., Cristescu, T., & Ebmeier, K. P. (2015). Establishing the cause of memory loss in older people.. PubMed.
62. Chuster, A. (2019). Long-lasting hypnagogic states of mind, sub-thalamic fears and caesura. Routledge eBooks. https://doi.org/10.4324/9780429444364-15
63. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. II. Stress and distress.. PubMed.
64. Cleeland, C. S., & Mendoza, T. R. (2010). Symptom measurement by patient report. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511780868.028
65. Cohen, J. A., Mowchun, J. J., Lawson, V. H., & Robbins, N. M. (2016). A 19-Year-Old Male with Stiffness and Weakness After Waking. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190491901.003.0026
66. Cohen, L. J., & Brody, D. S. (2015). Frontotemporal Dementia‐Like Syndrome Following Recall of Childhood Sexual Abuse. Journal of Traumatic Stress. https://doi.org/10.1002/jts.22016
67. Cohen‐Mansfield, J., Billig, N., Lipson, S., Rosenthal, A. S., & Pawlson, G. (1990). Medical Correlates of Agitation in Nursing Home Residents. Gerontology. https://doi.org/10.1159/000213191
68. Colombo, M. A. (2018). Insomnia disorder and endogenous neurophysiological dynamics.
69. Compton, M. T., & Broussard, B. (2010). Psychosocial Treatments for Early Psychosis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0016
70. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
71. Cotter, T. G., & Beresford, T. P. (2022). Treatment of Mental Health in Patients With Chronic Liver Disease. Clinical Liver Disease. https://doi.org/10.1002/cld.1200
72. Cruickshank, C., & Dyer, K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction. https://doi.org/10.1111/j.1360-0443.2009.02564.x
73. Cuevas, M. J. S. (2005). EL TRASTORNO POR DÉFICIT DE ATENCIÓN CON HIPERACTIVIDAD (314.01) Y SU INCIDENCIA EN EL MEDIO ESCOLAR, FAMILIAR Y SOCIAL EN EL CAMPO DE GIBRALTAR. Almoraima:  revista de estudios campogibraltareños.
74. Cunnington, D., & Junge, M. (2016). Chronic insomnia: diagnosis and non-pharmacological management. BMJ. https://doi.org/10.1136/bmj.i5819
75. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
76. Daley, M., & Cannon, T. D. (2010). Childhood Psychosis. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0172
77. David, G., Monge, M. P., Arántzazu, D., Fernanda, A., Fernanda, T. M., Gemma, M., & Sandra, D. (2016). Schizophrenia and sexual desinhibition. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.2162
78. Deonna, T. (2010). [Cognitive and behavioral consequences of epilepsy during the course of brain development].. PubMed.
79. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
80. Dieterich, M., Lempert, T., Huppert, D., & Brandt, T. (2009). Psychogenic disorders in neurology: frequency and clinical spectrum. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1990.tb03312.x
81. Djamshidian, A., Pagnier, G., Frank, M. J., & Friedman, J. H. (2022). Impulse Control Disorders and the Dopamine Dysregulation Syndrome. Cambridge University Press eBooks. https://doi.org/10.1017/9781009039291.021
82. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
83. Dodick, D. W., & Roarke, M. C. (2007). Familial Hemiplegic Migraine: Permanent Attack‐Related Neurologic Deficits. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2007.00889.x
84. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
85. Dragut, A. M., Danalache, I., Goanta, M., & Trifu, S. (2015). The Pathology of Cognitive and Language Disorganization–Between Hysteric Dissociation and Schizophrenic Split. Procedia - Social and Behavioral Sciences. https://doi.org/10.1016/j.sbspro.2015.03.081
86. Dubovický, M. (2010). Neurobehavioral manifestations of developmental impairment of the brain. Interdisciplinary Toxicology. https://doi.org/10.2478/v10102-010-0012-4
87. Dubovsky, S. (1994). Challenges in conceptualizing psychotic mood disorders.. PubMed.
88. Dudek, D., & Sobański, J. A. (2012). Mental disorders in somatic diseases: psychopathology and treatment. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.1539
89. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
90. Duntley, S. P. (2004). Insomnia in Primary Sleep Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_12
91. Dutta, A., Poudel, R., Thapa, L., & Pokhrel, B. (2014). Psychogenic Blindness: A Rare Presentation. Journal of Psychiatrists Association of Nepal. https://doi.org/10.3126/jpan.v2i2.9729
92. Ebenezer, I. S. (2015). Affective Disorders 1: Depression. https://doi.org/10.1002/9781118385777.ch6
93. Ebenezer, I. S. (2015). Sleep and Sleep Disorders. https://doi.org/10.1002/9781118385777.ch9
94. Economou, A., Papageorgiou, S. G., & Papanicolaou, A. C. (2005). Amnesias Associated with the Dementias. https://doi.org/10.1093/oso/9780195172454.003.0004
95. Emmett, S. R., Hill, N. A., & Dajas‐Bailador, F. (2019). Psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199694938.003.0018
96. Faget-Agius, C., & Lançon, C. (2015). [Acute delirium in decompensated schizophrenia and bipolar disorder].. PubMed.
97. Fahn, S., Greene, P., Ford, B., Bressman, S., & Frucht, S. J. (2009). Movement Disorders. https://doi.org/10.1007/978-1-57340-359-7_9
98. Falah, K., Attouche, N., Ajaoui, N., & Agoub, M. (2023). PSYCHOSE POST-ICTALE, UNE ENTITE CLINIQUE A CONNAITRE : A PROPOS DUN CAS HOSPITALISE AU CENTRE PSYCHIATRIQUE UNIVERSITAIRE DE CASABLANCA. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/16768
99. Fang, F. (2006). 慢性疼痛的评价和护理现状. Zhonghua xiandai huli zazhi. https://doi.org/10.3760/cma.j.issn.1674-2907.2006.09.010
100. Fava, G. A., & Cosci, F. (2019). Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.19com12794
101. Fenichel, G. M. (2022). Altered States of Consciousness. WORLD SCIENTIFIC eBooks. https://doi.org/10.1142/9789811260735_0011
102. Ferguson, E., & Cassaday, H. J. (2001). Theoretical Accounts of Gulf War Syndrome: From Environmental Toxins to Psychoneuroimmunology and Neurodegeneration. Behavioural Neurology. https://doi.org/10.1155/2002/418758
103. Feuerecker, R., Dieterich, M., Eckhardt‐Henn, A., & Becker‐Bense, S. (2015). Nicht-organischer Schwindel. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0034-1385272
104. Fiar, Z., Hroudov, J., & Raboch, J. (2012). Neurotransmission in Mood Disorders. InTech eBooks. https://doi.org/10.5772/31831
105. Fink, M. (2010). Depressive Mood Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0009
106. Fink, M. (2010). Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0011
107. Forrest, J., Willis, L., Holm, K., Kwon, M. S., Anderson, M. A., & Foreman, M. D. (2007). Recognizing quiet delirium.. PubMed. https://doi.org/10.1097/01.naj.0000265267.77070.0c
108. Francis, A. (2006). Update on Catatonia. The Psychiatric times.
109. Franz, M. R., & Schepank, H. (1997). [Mood disorders. Prevalence and course of unspecified functional disorders from the epidemiologic and psychosomatic viewpoint].. PubMed.
110. Freudenmann, R. W., Ileva, S., Ruf, W., Graf, H., & Meier, T. (2017). Dementiell-depressives Syndrom bei Chorea Huntington. Nervenheilkunde. https://doi.org/10.1055/s-0038-1627523
111. Fukuda, J. S., Pires, M. M., Fukuda, T. G., & Oliveira‐Filho, J. (2016). Atualização sobre diagnóstico e tratamento das demências rapidamente progressivas com base na experiência do Serviço. Revista Científica Hospital Santa Izabel. https://doi.org/10.35753/rchsi.v3i2.475
112. Gallais, B., Gagnon, C., Mathieu, J., Richer, L., Jean, S., & Laberge, L. (2014). Cognitive Deficits Associated with Sleep Apnea in Myotonic Dystrophy Type 1. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-140012
113. Galosi, S., Novelli, M., Rocco, M. D., Flex, E., Messina, E., Pollini, L., Parrini, E., Pisani, F., Guerrini, R., Leuzzi, V., & Martinelli, S. (2023). <scp><i>GNAO1</i></scp> Haploinsufficiency: The Milder End of the <scp><i>GNAO1</i></scp> Phenotypic Spectrum. Movement Disorders. https://doi.org/10.1002/mds.29585
114. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
115. Gautam, S., Jain, A., Gautam, M., Vahia, V., & Gautam, A. (2017). Clinical Practice Guidelines for the Management of Generalised Anxiety Disorder (GAD) and Panic Disorder (PD). Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.196975
116. Ghosh, S. (2015). Better understanding of etiopathology needed to develop novel treatments. Medicus.
117. Giannuzzi, R., Testa, A. C., Sollazzo, F., Petrongolo, L., Bernardini, L., & Daini, S. (2013). Psychiatric emergencies (part I): psychiatric disorders causing organic symptoms.. PubMed.
118. Goldstein, T. R. (2010). Bipolar Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0134
119. González, M. J., Bardanca, M. S. G., Vivanco, E. F., Paz, M. T. A., & Allegue, M. D. (2007). Distonía psicógena: un diagnóstico complejo..
120. Gonçalves, I. G., & Souza, M. C. A. D. (2023). Abordagem geral da doença de Parkinson. Revista Eletrônica Acervo Científico. https://doi.org/10.25248/reac.e12557.2023
121. Gortani, G. (2022). Approccio pratico al bambino “sempre stanco”. Medico e Bambino. https://doi.org/10.53126/meb41168
122. Goto, F., Morimoto, N., & Taiji, H. (2013). Two Cases of Pediatric Psychogenic Gait Disturbance. Nippon Jibiinkoka Gakkai Kaiho. https://doi.org/10.3950/jibiinkoka.116.91
123. Green, A. J. E., Andrews, M. M., Bishop, M., McKenzie, J. M., McCord, Y., Pennington, C., Chohan, G., & Knight, R. (2010). Elevated phosphorylated tau pT-181 in a possible PRNP codon 129 MV vCJD case. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2009.183418
124. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
125. Guerra, M. T., Rodrigo, M. V. L., Oliver, A. O., Monge, M. P., & Fominaya, M. P. (2022). “She gets out of control when she’s on her period”. Cyclic menstrual psychosis. A case report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1084
126. Gupta, K., & Mamidi, P. (2018). Deva grahonmada: Interictal behavior syndrome of temporal lobe epilepsy?/obsessive-compulsive disorder with mania?. International Journal of Yoga - Philosophy Psychology and Parapsychology. https://doi.org/10.4103/ijny.ijoyppp_24_17
127. Gupta, K., & Mamidi, P. (2022). Madonmada of Bhela samhita. Journal of Applied Consciousness Studies. https://doi.org/10.4103/ijoyppp.ijoyppp_16_21
128. Gutiérrez-Achury, A. M., Vanegas-Vidal, M., Salazar-Díaz, L. I., & Arías, G. M. A. (2009). Factores farmacológicos y no farmacológicos que afectan la adherencia al tratamiento de los pacientes esquizofrénicos dados de alta en la Unidad de Salud Mental del Hospital Universitario de Neiva entre enero y junio del 2008. RFS Revista Facultad de Salud. https://doi.org/10.25054/rfs.v1i2.43
129. Gómez‐Tortosa, E., Rigual, R., Prieto-Jurczynska, C., Mahíllo, I., Guerrero, R., Pérez‐Pérez, J., & Sainz, M. J. (2015). Behavioral Evolution of Progressive Semantic Aphasia in Comparison with Nonfluent Aphasia. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000439521
130. Halvorsen, H. T., Hammer, S. K., Nystrøm, V., & Leonardsen, A. L. (2019). Delirium hos intuberte intensivpasienter. iNSPIRA. https://doi.org/10.23865/inspira.v14.2784
131. Harvey, P. D. (2010). Schizophrenia, Functional Outcomes in. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0822
132. Hasan, S., & D’Adamo, M. C. (2015). Episodic Ataxia Type 1.
133. Haslam, R. H. A. (1997). Nonfebrile Seizures. Pediatrics in Review. https://doi.org/10.1542/pir.18.2.39
134. Hassan, M. S., Sidow, N. O., & Mohamed, N. A. (2022). Transient global amnesia: Uncommon diagnosis of exclusion. Clinical Case Reports. https://doi.org/10.1002/ccr3.6533
135. Heilman, K. M., Watson, R. T., & Valenstein, E. (2003). Neglect and Related Disorders. https://doi.org/10.1093/oso/9780195133677.003.0013
136. Helbig, M., Youssef, N., & Schuetz, S. (2023). 1001 A Case of Unusual Nocturnal Movements Consistent with Paroxysmal Hypnogenic Dyskinesia. SLEEP. https://doi.org/10.1093/sleep/zsad077.1001
137. Henry, T. R., & Moortele, P. V. D. (2009). Seizure disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139193481.036
138. Henríquez, M. R., Gómez, A. H., Balut, F., Hernández, V., & Perfetti, A. J. (2023). Trastorno de sueño inquieto: una nueva entidad clínica a considerar en niños. Andes pediatrica. https://doi.org/10.32641/andespediatr.v94i1.4203
139. Hirschfeld, R. M. A., Calabrese, J. R., Frye, M. A., Lavori, P. W., Sachs, G., Thase, M. E., & Wagner, K. D. (2007). Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.. PubMed.
140. Hj, A., Barrucand, D., & Auzépy, P. (1993). [Alcohol withdrawal syndrome and delirium tremens. Their treatment].. PubMed.
141. Hoban, T. F. (2001). Sleep-related rhythmic movement disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511711947.030
142. Hollender, M. H., & HIRSCH, S. J. (1964). HYSTERICAL PSYCHOSIS. American Journal of Psychiatry. https://doi.org/10.1176/ajp.120.11.1066
143. Hong, C. (2013). 분과 심포지움 2. 임상 : 새로운 진단체계 DSM-5; 조현병 스펙트럼 및 기타 정신병적 장애,성격장애. 한국심리학회 연차 학술발표논문집.
144. Hong, C. (2013). 조현병 스펙트럼 및 기타 정신병적 장애, 성격장애. 한국심리학회 학술대회 자료집.
145. Hosseinbor, N., & Bakhshani, N.-M. (2014). Djinnati Syndrome in Baluchistan: The Role of Traumatic and Abuse Experiences on Individual Vulnerability. international journal high risk behaviors & addiction. https://doi.org/10.5812/ijhrba.23610
146. Howland, R. H. (2010). Rapid Eye Movement Sleep. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1049
147. Hussain, E., Momin, A., Islam, M., Haque, S., Hossain, M. A., Chowdhury, R., & Hoque, A. (2016). Lafora Body Disease: A Rare Type of Progressive Myoclonic Epilepsy. American Journal of Medical Case Reports. https://doi.org/10.12691/ajmcr-4-3-2
148. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
149. Hȧrd, E., Archer, T., & Hansen, S. (2003). Animal Models of Mental Retardation. Humana Press eBooks. https://doi.org/10.1385/0-89603-177-2:273
150. In, K., & La, K. (1990). [The mechanism of death in whole-body overheating].. PubMed.
151. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
152. Ishizuka, K., Shikino, K., Li, Y., Yokokawa, D., Tsukamoto, T., Yanagita, Y., Kojima, J., Yamashita, S., Noda, K., Uehara, T., & Ikusaka, M. (2023). The differential diagnosis of medical and psychogenic disease in primary care. Journal of General and Family Medicine. https://doi.org/10.1002/jgf2.661
153. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
154. İbiloğlu, A. O., Atlı, A., Kaya, M. C., Baran, A. S., & Sır, A. (2016). Psychogenic Gait Disorder After a Stressful Life Event: Case Report. Turkiye Klinikleri Journal of Case Reports. https://doi.org/10.5336/caserep.2015-46732
155. Jablensky, A. (2012). Course and outcome of schizophrenia and their prediction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0078
156. Jaffee, M. S., Broshek, D. K., & Svingos, A. M. (2023). What Is a Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190630119.003.0001
157. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
158. Jaya, ⁠. A. (2019). Skizoafektif Tipe Mania. UMI Medical Journal. https://doi.org/10.33096/umj.v2i1.17
159. Jen, J. C. (2015). Familial Hemiplegic Migraine.
160. Jennum, P., Martiny, K., & Bech, P. (2009). [Insomnia].. PubMed.
161. Joshi, S., & Kapur, J. (2012). GABAA Receptor Plasticity during Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199746545.003.0041
162. Juruena, M. F. (2012). Understanding subthreshold depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.009
163. Kanchanatawan, B., & Kasantikul, D. (2007). Antipsychotic-induced tardive movement disorders: a series of twelve cases.. PubMed.
164. Kane, I., Light, M. J., Osewa, I., Nobler, M. S., & Siddiqi, N. (2017). Acute psychosis with manic features in patient with Fahrs syndrome: A Case report and Clinical review. Neuropsychiatry. https://doi.org/10.4172/neuropsychiatry.1000207
165. Kapfhammer, H. (2018). ACUTE AND LONG-TERM MENTAL AND PHYSICAL SEQUELAE IN THE AFTERMATH OF TRAUMATIC EXPOSURE – SOME REMARKS ON “THE BODY KEEPS THE SCORE”. Psychiatria Danubina. https://doi.org/10.24869/psyd.2017.254
166. Kapfhammer, H. (2018). ACUTE AND LONG-TERM MENTAL AND PHYSICAL SEQUELAE IN THE AFTERMATH OF TRAUMATIC EXPOSURE – SOME REMARKS ON “THE BODY KEEPS THE SCORE”. Psychiatria Danubina. https://doi.org/10.24869/psyd.2018.254
167. KARADENİZ, S., & KANDİL, S. (2017). Sleepwalking Improved with Fluoxetine Treatment in a Case of Obsessive Compulsive Disorder Accompanied by Sleepwalking. Turkish Journal of Pediatric Disease. https://doi.org/10.12956/tjpd.2017.318
168. Kaur, I., & Singal, A. (2019). Nail tic disorders. CRC Press eBooks. https://doi.org/10.1201/9781351139724-28
169. Khalafian, A., Dukes, C., & Tucker, P. (2015). Consultation Dilemma Catatonia in a Patient with Prior TBI: MentaI or Medical Disorder?. PubMed.
170. Kiese-Himmel, C. (2015). Klinisch-psychologische Bausteine in der Diagnostik funktioneller Dysphonien – eine Übersicht. Laryngo-Rhino-Otologie. https://doi.org/10.1055/s-0034-1394454
171. Kim, H. K. (2018). Myoclonic Status Epilepticus of Unknown Etiology in an Elderly Patient. Journal of Clinical Neurology. https://doi.org/10.3988/jcn.2018.14.1.100
172. Kim, J., Mi-Kyung, L., Choi, S.-S., Eui-Seok, P., & Gwi-Eun, Y. (2015). Continuous Cervical Epidural Block for Persistent Intractable Hiccups.
173. Kirakosyan, G. (2022). Understanding psychosis: diagnosis and clinical presentation (updates for clinicians). World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2022.13.1.0759
174. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
175. Kocabaşoğlu, N., Karaçetin, G., Bayar, R., & Demir, T. (2012). A Review of the Etiology Delirium. InTech eBooks. https://doi.org/10.5772/32411
176. Kocsis, J. H., & Brody, B. D. (2013). Chronic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.010
177. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
178. Krumholz, A., Sung, G., Fisher, R. S., Barry, E. F., Bergey, G. K., & Grattan, L. M. (1995). Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. https://doi.org/10.1212/wnl.45.8.1499
179. Kruse, R. (1990). [Psychomotor epilepsy: phenomenology, localization, pathogenesis and therapy].. PubMed.
180. Krystal, A. D. (2007). The Morbidity of Insomnia. CNS Spectrums. https://doi.org/10.1017/s1092852900026110
181. KS, M. C., Nagarajan., K., & Kanagarajan, A. (2023). Insomnia Management Clinical Trials by various Conventional Therapies – A Review. Research Journal of Pharmacy and Technology. https://doi.org/10.52711/0974-360x.2023.00985
182. Kulsum, U., Gupta, D., Ma, W., Polos, P., & Shah, B. (2018). 1098 Title-Sound Induced Drop Attacks, is it cataplexy or seizure?. SLEEP. https://doi.org/10.1093/sleep/zsy063.1097
183. Kučerová, H. P., Preiss, M., Bartoňová, P., & Přikryl, R. (2010). Kognitivní výkon u depresivní poruchy. Psychiatrie pro praxi.
184. Lance, J. W. (1996). Transient sensations of impending loss of consciousness: the "blip" syndrome.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.60.4.437
185. Larrabee, H., & Willard, L. A. (2014). Altered mental status. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139629058.008
186. Lavigne, G., Blanchet, P., Khoury, S., Carra, M. C., Rouleau, G. A., & Denis, R. (2010). Headache and sleep: guidance in recognition. Douleur et Analgésie. https://doi.org/10.1007/s11724-010-0207-7
187. Lawrie, S. M. (2010). Schizophrenia, bipolar disorder, obsessive–compulsive disorder, and personality disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260507
188. Ledezma, C., Soto, K., & Suárez, M. I. (2015). Depresión en el adulto mayor en Costa Rica: un problema social. Revista Hispanoamericana de Ciencias de la Salud.
189. Lee, S. C. (1990). Delayed Endolymphatic Hydrops. Journal of Clinical Otolaryngology Head and Neck Surgery. https://doi.org/10.35420/jcohns.1990.1.1.23
190. Levani, Y., Prastya, A. D., & Ramadhani, S. N. (2019). KLEPTOMANIA: MANIFESTASI KLINIS DAN PILIHAN TERAPI. MAGNA MEDICA Berkala Ilmiah Kedokteran dan Kesehatan. https://doi.org/10.26714/magnamed.6.1.2019.31-37
191. Lečić-Toševski, D. M., Pejović-Milovančević, M., Popović-Deušić, S., & Šušić (2007). [Psychiatric aspects of sleep].. PubMed.
192. Liddle, P. F. (2012). Descriptive clinical features of schizophrenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0072
193. Lievre, J. L., Schweitzer, R., & Barnard, A. (2012). The subjective experience of negative symptoms: Characteristics of emotional withdrawal.
194. Lisk, D. R. (2009). Kleine–Levin syndrome. Practical Neurology. https://doi.org/10.1136/jnnp.2008.161950
195. Littner, M. R., Hirshkowitz, M., Kramer, M., Kapen, S., Anderson, W. M., Bailey, D. R., Berry, R. B., Davila, D., Johnson, S., Kushida, C. A., Loube, D. I., Wise, M. S., & Woodson, B. T. (2003). Practice Parameters for Using Polysomnography to Evaluate Insomnia: An Update. SLEEP. https://doi.org/10.1093/sleep/26.6.754
196. Lo, S. E., & Frucht, S. J. (2012). Myoclonus. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_5
197. Lockhart, P. J. (2001). Fetal alcohol spectrum disorders for mental health professionals - a brief review. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200109000-00007
198. Loitman, J. E., & Deshields, T. L. (2010). Psychiatric Palliative Care Issues. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-590-3_4
199. Lucchesi, L. M., Pradella-Hallinan, M., Lucchesi, M., & Moraes, W. A. D. S. (2005). O sono em transtornos psiquiátricos. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462005000500006
200. Luisetto, M. (2018). Mindset kinetics and Some Depression Status: A New Quantitative Model Under Biochemical-Toxicology Approach?. Journal of pharmacology & clinical research. https://doi.org/10.19080/jpcr.2018.05.555680
201. Lukačević, M. (2016). Depresivnost djece u primarnom obrazovanju.
202. Lyketsos, C. G. (2012). F1‐01‐02: Tackling overlap of neuropsychiatric symptoms in Alzheimer's and other dementias: Toward a unified approach to evaluation and treatment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2012.05.191
203. Lütschg, J., Zaugg, C., & Hassink, R. (2012). Neuropédiatrie: Rare mais importante: la dystonie dopa-sensible ou syndrome de Segawa (DYT5). Forum Médical Suisse ‒ Swiss Medical Forum. https://doi.org/10.4414/fms.2012.01378
204. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
205. Macovei, A. L., Dobrin, I., Chiriță, V., Burlui, A., Dobrin, P.-R., & Rezuş, E. (2019). Chronic fatigue and psychiatric comorbidities in patients with rheumatic disorders. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2019.03.08
206. MacPherson, H. A. (2019). More than medication: The importance of family treatments for pediatric bipolar disorder. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30433
207. Madrigal, J. G. T. (2012). Status epiléptico en emergencias: manejo tradicional y tendencia actual. Revista Médica de Costa Rica y Centroamérica.
208. Madruga, M. L. L. H., Melo, G. B., Martins, J. M., Aranha, R. E. L. D. B., Marinho, J. C. R. L., Alves, N. T., Estudo, E., Revisão, U., & Literatura, D. (2018). Estudo Eletroencefalográfico De Indivíduos Com Dor Crônica Decorrente Da Fibromialgia: Uma Revisão Da Literatura. Scientific Research and Reviews. https://doi.org/10.28933/srr-2018-06-28100
209. Magron, P., Hida, H., & Beauchamp, I. D. (2001). Le syndrome sérotoninergique. Journal de Pharmacie Clinique.
210. Maj, M. (2023). Understanding depression beyond the “mind‐body” dichotomy. World Psychiatry. https://doi.org/10.1002/wps.21142
211. Majeske, M., Nistor, V., & Kellner, C. H. (2016). Late‐Life Psychosis. https://doi.org/10.1002/9781118654231.ch35
212. Malterud, K., & Aamland, A. (2019). Medically unexplained symptoms: are we making progress?. British Journal of General Practice. https://doi.org/10.3399/bjgp19x701885
213. Mani, J. (2022). Nonconvulsive status epilepticus (NCSE). Bombay Hospital Journal. https://doi.org/10.15713/ins.bhj.77
214. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
215. Maramis, M. M. (2009). Mendiagnosis Gangguan Bipolar pada Fase Depresi sejak dini.
216. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
217. Marchand, W. R. (2009). Attention-Deficit/Hyperactivity Disorder: Review Questions.
218. Mauri, M. C. (2016). Drug Induced Psychosis or Schizophrenia?. Dual Diagnosis Open Access. https://doi.org/10.21767/2472-5048.100011
219. Maxwell, R. A., & Eckhardt, S. B. (1990). Imipramine. Drug Discovery. https://doi.org/10.1007/978-1-4612-0469-5_10
220. McAskill, R., & Taylor, D. (1997). Psychotropics and hyponatraemia. Psychiatric Bulletin. https://doi.org/10.1192/pb.21.1.33
221. McCrory, P. (2001). The nature of concussion: a speculative hypothesis. British Journal of Sports Medicine. https://doi.org/10.1136/bjsm.35.3.146
222. McKenna, P. J., & Oh, T. M. (2001). Thought disorder as a syndrome in schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544057.003
223. Medina, A. B., Lechuga, D. A., Escandón, O. S., & Moctezuma, J. V. (2014). Update of sleep alterations in depression. Sleep Science. https://doi.org/10.1016/j.slsci.2014.09.015
224. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
225. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
226. Medrano‐Martínez, P., Platón, M., & Peraita‐Adrados, R. (2018). Alteraciones neuropsicológicas en la narcolepsia con cataplejía: una revisión. Revista de Neurología. https://doi.org/10.33588/rn.6603.2017448
227. Mervis, C. Β., Morris, C. A., Klein-Tasman, B., Velleman, S. L., & Osborne, L. R. (2015). 7q11.23 Duplication Syndrome.
228. Messina, G., Franzini, A., Cecchini, A. P., & Leone, M. (2016). ONS and DBS for the Treatment of Chronic Cluster Headache. InTech eBooks. https://doi.org/10.5772/64482
229. Meza-Ruiz, W., & Zúñiga-Escobar, G. (2023). Hematoma cerebral intraparenquimatoso e intraventricular por cocaína: reporte de un caso. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272023000100064
230. Miceli, F., Soldovieri, M. V., Joshi, N., Weckhuysen, S., Cooper, E. C., & Taglialatela, M. (2016). KCNQ2-Related Disorders.
231. Michal, M. (2022). Depersonalization/Derealization Disorder. Routledge eBooks. https://doi.org/10.4324/9781003057314-29
232. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
233. Miller, S. P., & Latal, B. (2009). Neurocognitive outcomes of term infants with perinatal asphyxia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581281.050
234. MM, B., Islam, S., Nh, S., Rahman, M., & Bari, M. (2016). None. MOJ Orthopedics & Rheumatology. https://doi.org/10.15406/mojor.4.1
235. Montes, A. B., & Rey, J. A. (2009). Iloperidone (Fanapt): An FDA-Approved Treatment Option for Schizophrenia. P & T.
236. Monti, M. M., Laureys, S., & Owen, A. M. (2010). The vegetative state. BMJ. https://doi.org/10.1136/bmj.c3765
237. Mossaheb, N., Schloegelhofer, M., Schaefer, M., Fusar‐Poli, P., Smesny, S., McGorry, P. D., Berger, G., & Amminger, G. P. (2012). Long-Chain Omega-3 Fatty Acids and Psychotic Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-215-5_9
238. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
239. Mucci, V., Sussetto, M., Ranieri, M., Cavuscens, S., Fornos, A. P., & Guinand, N. (2019). [The Mal de Débarquement Syndrome].. PubMed.
240. Munro, A. (1999). Delusional Disorder: Paranoia and Related Illnesses.
241. Myathari, R., Gupta, A., & Bijarnia‐Mahay, S. (2022). Novel mutation in DMN1L gene in child with Landau Kleffner syndrome: a rare association. International Journal of Contemporary Pediatrics. https://doi.org/10.18203/2349-3291.ijcp20222127
242. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
243. Nadkarni, S., Arnedo, V., & Devinsky, O. (2007). Psychosis in epilepsy patients. Epilepsia. https://doi.org/10.1111/j.1528-1167.2007.01394.x
244. Naidu, B. M. (2016). Drug Abuse in India. International journal of research in social sciences.
245. Neto, B. P. F. (2009). Catatonia with Left Temporal Lesion on MRI: Crossing Borders. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70960-5
246. Nguyen‐Michel, V., Solano, O., Lambrecq, V., Dupont, S., Adam, C., & Arnulf, I. (2015). Complex periodic limb movements during sleep or partial epileptic seizures?. Neurology. https://doi.org/10.1212/wnl.0000000000002224
247. Nieto-Pico, A. M., Rueda-Vargas, A., & Mora-Bautista, V. M. (2019). Trastornos por tics en niños: un caso con retraso diagnóstico. CES Medicina. https://doi.org/10.21615/cesmedicina.33.2.6
248. Ninaprilia, Z., & Rohmani, C. F. (2015). Gangguan Mood Episode Depresi Sedang. Jurnal Medula.
249. Ntchana, A. (2022). A Case of Brief Psychotic Disorder: An Unintended Consequence of COVID-19 Virus. American Journal of Biomedical Science & Research. https://doi.org/10.34297/ajbsr.2022.16.002239
250. Ntchana, A. (2022). A Case of Brief Psychotic Disorder: An Unintended Consequence of COVID-19 Virus. Psychology & Psychological Research International Journal. https://doi.org/10.23880/pprij-16000300
251. Nunes, F. D. D., Freitas, P. H. B. D., Pinto, J. A. F., Souza, A. R. S., & Machado, R. M. (2016). Análise da prevalência de Síndrome Metabólica e fatores de risco associados em pacientes com Esquizofrenia Refratária. 12º Congresso Internacional da Rede Unida.
252. Obeso, J. Á., Guridi, J., & DeLong, M. R. (1997). Surgery for Parkinson's disease.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.62.1.2
253. Olmos-López, A., Ibarra-Aguilar, J., Cornelio-Nieto, J. O., Ocaña-Hernández, L. A., Márquez-Amaya, M. A., Luna-López, N. A., Reséndiz-Aparicio, J. C., & Rodríguez‐Leyva, I. (2019). Clinical guideline: status epilepticus in children and adults. DELETED. https://doi.org/10.24875/rmn.m19000031
254. Olowoyo, P., Oguntoye, O., Akinbote, J. A., & Akinyemi, M. O. R. (2018). Recurrent Prolonged Epileptic Fugue State Misdiagnosed as Psychosis? Tale of a Middle-Aged Female Nigerian African. International Journal of Innovative Research in Medical Science. https://doi.org/10.23958/ijirms/vol02-i09/04
255. Olson, D. M., Westermarck, T., & Ekvall, S. W. (2005). Seizures And Epilepsy. https://doi.org/10.1093/oso/9780195165647.003.0010
256. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
257. Osterman, J. E., Erdos, B. Z., Oldham, M., & Ivkovic, A. (2010). Antidepressant Treatments in PTSD. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-435-7_7
258. Owen, D. R., Paranandi, B., Ramachandran, S., & Seevaratnam, M. (2007). Classical diseases revisited: transient global amnesia. Postgraduate Medical Journal. https://doi.org/10.1136/pgmj.2006.052472
259. O’Halloran, E., Branagan, A., Canty, N., Michael, O., & Stokes, H. (2019). P407 Conversion disorder: don’t be mistaken, don’t be misled. Abstracts. https://doi.org/10.1136/archdischild-2019-epa.753
260. Packard, R. C., & Ham, L. P. (1993). Impairment Ratings for Posttraumatic Headache. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.1993.hed3307359.x
261. Padmos, R. C. (2009). Inflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases.
262. Palmeri, M., & Barr, W. (2023). B - 81 Neuropsychological Case Study: Transient Amnesia or “Sentinel Seizure?” Potential Prodromal Symptoms of an ACoA Aneurysm Rupture. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acad067.287
263. Pan, E., Algül, A., Başoğlu, C., Ebrinç, S., Ateş, M. A., Semiz, Ü., Şenol, M. G., & Çetin, M. (2010). P01-294 - Depression and Agoraphobia in a Patient with Myasthenia Gravis. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70502-2
264. Pandya, D., Shinkar, D. M., & Saudagar, R. B. (2016). Kleptomania: An overview. Asian Journal of Pharmacy and Technology. https://doi.org/10.5958/2231-5713.2016.00017.9
265. Paparrigopoulos, T., Tzavellas, E., Karaiskos, D., Kouzoupis, A. V., & Liappas, I. (2010). Complete recovery from undertreated Wernicke-Korsakoff syndrome following aggressive thiamine treatment..
266. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
267. Pary, R., Lippmann, S., & Tobias, C. R. (1994). Obsessive-compulsive disorder. Postgraduate Medicine. https://doi.org/10.1080/00325481.1994.11945941
268. Patel, K., & Samani, M. (2018). Childhood disintegrative disorder. Annals of Indian Psychiatry. https://doi.org/10.4103/aip.aip_47_17
269. Pavone, P., Corsello, G., Ruggieri, M., Marino, S., Marino, S. D., & Falsaperla, R. (2018). Benign and severe early-life seizures: a round in the first year of life. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/s13052-018-0491-z
270. Paw, H., & Shulman, R. (2014). Management of status epilepticus. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316182673.042
271. Pereira, D. A., Wildenberg, B., Carvalho, I., & Madeira, N. (2022). Epileptic Seizures or not, that is the question: a case report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1001
272. Persinger, M. A. (2016). Answers to Two Questions Consistently Reflect Cerebral Dysfunction or Damage Subsequent to Mild Closed Head Injuries and Protracted Difficulties with Adaptation. Journal of Neurological Disorders. https://doi.org/10.4172/2329-6895.1000277
273. Piacentini, J., & Bennett, S. M. (2010). Tourette's Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1001
274. Piendl, T. A. (2015). Auswirkungen von depressiven Störungen auf die kognitive Leistungsfähigkeit und die Fahrkompetenz.
275. Pigato, G., Roiter, B., Cecchin, D., Morbelli, S., Tenconi, E., Minelli, A., & Bortolomasi, M. (2016). Electroconvulsive Therapy in a Patient With Chronic Catatonia. Journal of Ect. https://doi.org/10.1097/yct.0000000000000333
276. Pontius, A. A. (1993). NEUROPSYCHIATRIC UPDATE OF THE CRIME "PROFILE" AND "SIGNATURE" IN SINGLE OR SERIAL HOMICIDES: RULE OUT LIMBIC PSYCHOTIC TRIGGER REACTION. Psychological Reports. https://doi.org/10.2466/pr0.1993.73.3.875
277. Pontius, A. A. (1993). Neuropsychiatric Update of the Crime “Profile” and “Signature” in Single or Serial Homicides: Rule out Limbic Psychotic Trigger Reaction<sup>1</sup>. Psychological Reports. https://doi.org/10.1177/00332941930733pt125
278. Pontius, A. A. (2001). Homicides with Partial Limbic Seizures: Is Chemical Seizure Kindling the Culprit?. International Journal of Offender Therapy and Comparative Criminology. https://doi.org/10.1177/0306624x01454010
279. Popkirov, S., Asadi‐Pooya, A. A., Duncan, R., Gigineishvili, D., Hingray, C., Kanner, A. M., LaFrance, W. C., Pretorius, C., & Reuber, M. (2019). The aetiology of psychogenic non‐epileptic seizures: risk factors and comorbidities. Epileptic Disorders. https://doi.org/10.1684/epd.2019.1107
280. Prasad, K., Prasad, M., Ramaratnam, S., & Marson, A. G. (2015). Status epilepticus. https://doi.org/10.1002/9781119067344.ch9
281. Praško, J., Raszka, M., & Pastucha, P. (2009). Dissociative Disorders - Clinical Manifestation and Management. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70376-1
282. Putra, H. G. S. A. (2015). GANGGUAN AFEKTIF BIPOLAR MANIA DENGAN PSIKOTIK: SEBUAH LAPORAN KASUS. DOAJ (DOAJ: Directory of Open Access Journals).
283. Pérez, P. S. (2015). El déficit cognitivo en el síndrome de fatiga crónica: factores asociados y evolución.
284. Pérez, Y. M. M., Ortega, D. L. G., & Torres, S. V. L. (2022). AGITACIÓN PSICOMOTRIZ. PUERTO MADERO EDITORIAL eBooks. https://doi.org/10.55204/pmea.3.c10
285. Pérez, Á. M. S., Granados, F. J. V., Salazar, M. H., Méndez, A. Z., & Dávalos, É. M. (2005). Síndrome prefrontal ventromedial. Reporte de caso. Neurología, Neurocirugía y Psiquiatría.
286. Pérez-Romero, J. L., Hernández‐Fernández, F., Moratalla, A. B. P., Ayo‐Martín, Ó., & Rubio, M. E. O. (2010). Síncopes de Repetición como presentación de Encefalopatía de Wernicke-Korsakov. Revista Clínica de Medicina de Familia. https://doi.org/10.4321/s1699-695x2010000200017
287. Pétursson, H. (1994). The benzodiazepine withdrawal syndrome. Addiction. https://doi.org/10.1111/j.1360-0443.1994.tb03743.x
288. Rachmani, S., & Mayasari, D. (2017). Kombinasi Farmakoterapi dan Psikoterapi Pada Pengobatan Episode Depresif Sedang Dengan Gejala Somatis. Jurnal Medula.
289. Rades, M., & Wulandari, A. J. (2016). Skizoafektif Tipe Campuran. Jurnal Medula.
290. Rafael, M. D. S., Carreira, E. X., Alves, L. P. L., Carvalho, A. N. D., Jaeger, A., Teixeira, A. L., & Souza, L. C. D. (2017). Amnésia global transitória: epidemiologia, fisiopatologia, clínica e terapêutica. Revista Brasileira de Neurologia.
291. Raja, S., Kotturu, M. K., Kandriga, V. K. R., & Potla, V. K. (2022). A rare case of early onset childhood schizophrenia with predominant negative symptoms. International Journal of Contemporary Pediatrics. https://doi.org/10.18203/2349-3291.ijcp20221082
292. Ridder, D. D. (2007). Brain and Nerve Stimulation for Mood Enhancement. Philosophica. https://doi.org/10.21825/philosophica.82182
293. Riddle, M. A., King, R. A., Hardin, M. T., Scahill, L. D., Ort, S. I., Chappell, P., Rasmusson, A. M., & Leckman, J. F. (1990). Behavioral Side Effects of Fluoxetine in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.1990.1.193
294. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
295. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.3917/rne.043.0196
296. Rm, S. (1990). [Causalgia in neurologic expert assessment].. PubMed.
297. Roberts, A. R., & Yeager, K. R. (2009). Stress Symptomatology and the General Adaptation Syndrome. https://doi.org/10.1093/oso/9780195382907.003.0008
298. Rosenbaum, J. F., & Zajecka, J. (1997). Clinical management of antidepressant discontinuation.. PubMed.
299. Roth, T., Krystal, A. D., & Lieberman, J. A. (2007). Long-term issues in the treatment of sleep disorders.. CNS Spectrums.
300. ROY, R., Kumar, S. P., & Kishor, M. (2022). A Case of Trichotillomania With Comorbid Depression And Anxiety. Digital Journal of Clinical Medicine. https://doi.org/10.55691/2582-3868.1004
301. Roy‐Byrne, P. (2001). The Neuroanatomy of Hysterical Paralysis. Journal watch. https://doi.org/10.1056/jp200107260000001
302. Sa, H. (2013). Diabetes Mellitus And The Brain: Special Emphasis To Cognitive Function. International Journal of Diabetology & Vascular Disease Research. https://doi.org/10.19070/2328-353x-130007
303. Safei, I., & Darwis, M. Z. (2022). Tatalaksana Layanan Rehabilitasi Medik Pasien dengan Dekondisi Imobilisasi : Literature Review. UMI Medical Journal. https://doi.org/10.33096/umj.v7i1.163
304. Samico, A., & Venâncio, Â. (2019). A Rare Case of Non Convulsive Status Epileptic with Psychotic Presentation. Neuropsychiatry. https://doi.org/10.4172/neuropsychiatry.1000545
305. Sander, R. (2009). A treatment for Parkinson’s disease, but no improvement for dementia. Nursing Older People. https://doi.org/10.7748/nop.21.2.31.s28
306. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
307. Santeusanio, F. (2012). Quadri internistici ed endocrinologici connessi alla disabilitŕ grave. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003010
308. Saravi, S. F. B., Sheykhmoonesi, F., Abbasgholizadeh, B., Jafari, D., & Shariatzadeh, H. (2013). Ten Year Chronic Conversion Disorder Associated with Abnormal Posture in Elbow: A Case Report. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences.
309. Sarkar, S., & Dinesh, M. (2023). The threshold problem of impairment criteria in psychiatric diagnosis. Journal of SAARC Psychiatric Federation. https://doi.org/10.4103/jspf.jspf_12_23
310. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
311. Schildkrout, B. (2014). Delusional Thought Content. https://doi.org/10.1002/9781394260447.ch7
312. Schildkrout, B. (2014). Dementia. https://doi.org/10.1002/9781394260447.ch12
313. Schildkrout, B. (2014). Disease #22: Hypersomnia, Idiopathic. https://doi.org/10.1002/9781394260447.ch50
314. Schildkrout, B. (2014). Disease #35: Migraine. https://doi.org/10.1002/9781394260447.ch63
315. Schildkrout, B. (2014). Disease #49: Partial Seizures. https://doi.org/10.1002/9781394260447.ch77
316. Schildkrout, B. (2014). Disease #53: Postconcussion Syndrome. https://doi.org/10.1002/9781394260447.ch81
317. Schildkrout, B. (2014). Disease #57: <scp>REM</scp> Sleep Behavior Disorder. https://doi.org/10.1002/9781394260447.ch85
318. Schildkrout, B. (2014). Hallucinations. https://doi.org/10.1002/9781394260447.ch8
319. Schuler, S. (1994). [Psychopathology of drug dependent patients following detoxification].. PubMed.
320. Schwartz, B. (1990). Early information processing in schizophrenia.. PubMed.
321. Seitz, R. J. (2005). Cerebral reorganization after sensorimotor stroke. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316135297.005
322. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
323. Sexmero, M. M., Carrasco, I. S., Cerejeira, J. G., Lozano, M. F., Ramírez, A. G., Viuda, M. Q. D. L. D. L., Valera, G. G., Adame, C. V., Lobo, C. D. A., Aparicio, T. J., Rodríguez, B. R., Barriga, N. N., Pérez, E. R., & Borge, L. G. (2022). Mutism. What to expect?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1507
324. Sharpe, M. (2010). Chronic fatigue syndrome (postviral fatigue syndrome, neurasthenia, and myalgic encephalomyelitis). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260504
325. SheikhBahaei, S., Farhan, M., & Maguire, G. A. (2022). Improvement of stuttering after administration of methylphenidate - a case report. Personalized Medicine in Psychiatry. https://doi.org/10.1016/j.pmip.2022.100092
326. Shibasaki, H., & Hallett, M. (2016). Psychogenic Neurologic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190240974.003.0026
327. Siddiqui, J. A., Qureshi, S. F., & Ghamdi, A. K. A. (2017). Alien Abductions: A Case of Sleep Paralysis. Sleep and Hypnosis. https://doi.org/10.5350/sleep.hypn.2017.19.0144
328. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
329. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
330. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
331. Skokauskas, N., Pillay, D., Moran, T., & Kahn, D. (2010). Transient Auditory Hallucinations in an Adolescent. Journal of Psychiatric Practice. https://doi.org/10.1097/01.pra.0000375716.77831.ca
332. Small, G. A., & Milliron, M. (2023). Weakness. Cambridge University Press eBooks. https://doi.org/10.1017/9781316338513.007
333. Snaith, P. (1994). Anxiety Control Training. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.1.2.57
334. Soares, E. B., Pires, J. B., Menezes, M. D. A., Santana, S. K. S. D., & Fraga, J. (2010). Fonoaudiologia X ronco/apneia do sono. Revista CEFAC. https://doi.org/10.1590/s1516-18462010000200019
335. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
336. Soyka, M. (2009). Psychotische Störungen durch Alkohol. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628675
337. Stern, T. A., & Murray, G. B. (1984). Complex Partial Seizures Presenting as a Psychiatric Illness. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-198410000-00006
338. Stewart, S. M. (2013). Depression. The Encyclopedia of Cross‐Cultural Psychology. https://doi.org/10.1002/9781118339893.wbeccp158
339. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
340. Straszek, S. P., Licht, R. W., Nielsen, R. E., & Vinberg, M. (2022). [Bipolar depression, a challenge diagnostic and treatmentwise].. Research Portal Denmark.
341. Stringer, S., Nieman, D. H., Kahn, R. S., & Derks, E. M. (2015). Genome-wide association analysis in schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781107337459.010
342. Suarez, J. M. (2018). ESQUIZOFRENIA CON SÍNTOMAS NEGATIVOS Y TEC: REPORTE DE CASO. Revista Edu-Física.
343. Tabaasum, N., & Islam, F. (2022). Schizoid personality disorder: a rare type. Bangladesh Journal of Psychiatry. https://doi.org/10.3329/bjpsy.v36i2.72753
344. TAKANASHI, M. (2010). パーキンソン病の非運動症状. Juntendō Igaku/Juntendo igaku. https://doi.org/10.14789/pjmj.56.444
345. Tariq, F. (2012). Premature Ejaculation Re-Visited: Definition and Contemporary Management Approaches. InTech eBooks. https://doi.org/10.5772/25670
346. Taylor, M. A. (1999). Bipolar Mood Disorders. https://doi.org/10.1093/oso/9780195130379.003.0008
347. Taylor, M. A. (1999). Personality And Personality Disorders. https://doi.org/10.1093/oso/9780195130379.003.0006
348. Tedyanto, E. H., Adnyana, I. M. O., & Widyadharma, I. P. E. (2023). Tension-type Headache and Migraine as Manifestations of Chronic Post-Traumatic Headache. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v50i2.528
349. Terrés-Jiménez, B., Domínguez-Cabañero, E. M., González-Vivas, C., García-Parreño, B., Diego-Castaño, S., Gesler, M. A., Entrambasaguas, M. D., & Lorente-Rovira, E. (2022). Variables associated with the success of group cognitive behavioral therapy for insomnia: preliminary results.. PubMed.
350. Thomas, N., & Pantelis, C. (2015). Psychotic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp535
351. Thomas, P. (2003). Non convulsive status epilepticus of frontal origin. Epileptic Disorders.
352. Thomas, P. (2003). Treatment options for acute mania. European Psychiatry. https://doi.org/10.1016/s0924-9338(03)80011-1
353. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
354. Tickner, N., Apps, J., Keady, S., & Sutcliffe, A. (2012). An overview of drug therapies used in the treatment of dystonia and spasticity in children. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/archdischild-2011-301170
355. Tiller, J., & Schweitzer, I. (2010). Bipolar disorder: diagnostic issues. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2010.tb03889.x
356. Tokuda, N., Kondo, M., Kasai, T., Kimura, A., Nakagawa, M., & Mizuno, T. (2015). A case of pure alexia and foreign accent syndrome following acute encephalopathy in the presence of anti-glutamate receptor antibodies. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.cn-000735
357. Tomaz, B. C. A., Costallat, G. L., & Henna, E. (2017). Prolonged Hypomanic, Five Years Running Wild: Case Report. SM Journal of Depression Research and Treatment. https://doi.org/10.36876/smjdrt.1014
358. Torpy, J. M. (2010). Delirium. JAMA. https://doi.org/10.1001/jama.304.7.814
359. Treanor, M., & Roemer, L. (2010). Generalized Anxiety Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0379
360. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
361. Tugendhaft, P. (2004). [The follow-up of antiepileptic drugs].. PubMed.
362. Unknown (2017). Brief Psychotic Disorder. The SAGE Encyclopedia of Abnormal and Clinical Psychology. https://doi.org/10.4135/9781483365817.n218
363. Utiumi, M. A. T., Munhoz, R. P., Cartaxo, C., & Teive, H. A. G. (2012). Complex movement disorder in an elderly patient and the chimera effect. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2012000500014
364. Valente, S. M. (2015). Evaluating and Managing Insomnia: Non-pharmacological Treatments. Journal of Sleep Disorders & Therapy. https://doi.org/10.4172/2167-0277.1000189
365. Varghese, R., John, D., & Arun, M. (2007). A case of primary hypersomnia. Annals of Indian Academy of Neurology. https://doi.org/10.4103/0972-2327.31489
366. Varughese, A., Sachidan, & Peteru (2019). Specific Phobia vs Panic Disorder in Children: A Unique Case Report and Review of Literature. Journal of Depression & Anxiety.
367. Vicente, S. B., Tavares, M. B., & Siqueira, E. C. D. (2023). Síndrome de Tourette. Revista Eletrônica Acervo Médico. https://doi.org/10.25248/reamed.e12923.2023
368. Wahyuni, A. A. S., WIGUNA, I. G. R. P., & Aditya, M. R. (2023). WAHAM SOMATIK : SEBUAH TINJAUAN PUSTAKA. Jurnal Hasil Penelitian dan Pengembangan (JHPP). https://doi.org/10.61116/jhpp.v1i3.156
369. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
370. Walker, M. C., Cockerell, O., & Sander, J. W. (1996). Non-Convulsive Status Epilepticus Presenting as a Psychiatric Condition. Journal of the Royal Society of Medicine. https://doi.org/10.1177/014107689608900209
371. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
372. Weber, P., Vepřeková, B., & Kadaňka, Z. (2009). Psychiatrická problematika v intenzivní medicíně vyššího věku.
373. Weisholtz, D. S., & Dworetzky, B. A. (2014). Epilepsy and Psychosis.
374. Wentzlaff, S., Knauss, J., & Mohr, S. (2012). Fallbericht: Dementia Pugilistica (D.P.) bzw. chronisch traumatische Encephalopathie. Zeitschrift für Neuropsychologie. https://doi.org/10.1024/1016-264x/a000069
375. Wichaidit, B. T., Rask, C. U., & Østergaard, J. R. (2014). [Diagnosing functional seizures in children and adolescents].. Research Portal Denmark.
376. Wieling, W., Thijs, R. D., Dijk, N. V., Wilde, A. A., Benditt, D. G., & Dijk, J. G. V. (2009). Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain. https://doi.org/10.1093/brain/awp179
377. Williams, M. D. (2018). Dynamique de l’excitabilité corticale dans l’épilepsie-absence et intégration sensorielle.
378. Willner, P. (1984). Drugs, Biochemistry, and Conscious Experience: Toward a Theory of Psychopharmacology. Perspectives in biology and medicine. https://doi.org/10.1353/pbm.1984.0009
379. Woo, C. H., & Kim, S. (2014). Effectiveness of the Military Mental Health Promotion Program. Journal of Korean Academy of Nursing. https://doi.org/10.4040/jkan.2014.44.6.717
380. Yanti, L., Andari, F. N., Novriadi, D., & Ferasinta, F. (2022). PENURUNAN INSOMNIA PADA LANSIA DENGAN TERAPI ZIKIR. Jurnal Pengabdian Masyarakat Bumi Raflesia. https://doi.org/10.36085/jpmbr.v5i3.3859
381. Yersin, B. (1999). [Ambulatory management of alcohol withdrawal syndrome].. PubMed.
382. Yutzy, S. H. (2015). Somatic Symptom and Related Disorders: Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch62
383. Zauner, J. (1978). [Psychosomatic aspects of adolescence].. PubMed.
384. Şenel, G. B., & Karadeniz, D. (2022). Neuroanatomical and Etiological Approaches to Secondary Narcolepsy. Neurological Sciences and Neurophysiology. https://doi.org/10.4103/nsn.nsn_5_22